181 related articles for article (PubMed ID: 23076542)
1. Reduction of splenic volume by steroid therapy in cases with autoimmune pancreatitis.
Matsubayashi H; Uesaka K; Kanemoto H; Aramaki T; Nakaya Y; Kakushima N; Ono H
J Gastroenterol; 2013 Aug; 48(8):942-50. PubMed ID: 23076542
[TBL] [Abstract][Full Text] [Related]
2. Autoimmune pancreatitis complicated by gastric varices: a report of 3 cases.
Goto N; Mimura J; Itani T; Hayashi M; Shimada Y; Matsumori T
World J Gastroenterol; 2012 Aug; 18(31):4228-32. PubMed ID: 22919259
[TBL] [Abstract][Full Text] [Related]
3. Early pancreatic volume reduction on CT predicts relapse in patients with type 1 autoimmune pancreatitis treated with steroids.
Ohno Y; Kumagi T; Yokota T; Azemoto N; Tanaka Y; Tange K; Inada N; Miyata H; Imamura Y; Koizumi M; Kuroda T; Hiasa Y;
Orphanet J Rare Dis; 2016 Jul; 11(1):103. PubMed ID: 27465035
[TBL] [Abstract][Full Text] [Related]
4. Is (18)F-fluorodeoxyglucose positron emission tomography meaningful for estimating the efficacy of corticosteroid therapy in patients with autoimmune pancreatitis?
Shigekawa M; Yamao K; Sawaki A; Hara K; Takagi T; Bhatia V; Nishio M; Tamaki T; El-Amin H; Sayed Zel-A; Mizuno N
J Hepatobiliary Pancreat Sci; 2010 May; 17(3):269-74. PubMed ID: 19727541
[TBL] [Abstract][Full Text] [Related]
5. Gastric varices and splenic vein obstruction during steroid treatment for autoimmune pancreatitis: A case report and literature review.
Juarez LA; Gupta RR; Ruhnke GW
Medicine (Baltimore); 2018 Aug; 97(34):e11940. PubMed ID: 30142813
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune pancreatitis: CT patterns and their changes after steroid treatment.
Manfredi R; Graziani R; Cicero C; Frulloni L; Carbognin G; Mantovani W; Mucelli RP
Radiology; 2008 May; 247(2):435-43. PubMed ID: 18430876
[TBL] [Abstract][Full Text] [Related]
7. Peripancreatic vascular involvements of autoimmune pancreatitis.
Ishikawa T; Itoh A; Kawashima H; Ohno E; Itoh Y; Nakamura Y; Hiramatsu T; Miyahara R; Ohmiya N; Haruta J; Goto H; Hirooka Y
J Gastroenterol Hepatol; 2012 Dec; 27(12):1790-5. PubMed ID: 22849535
[TBL] [Abstract][Full Text] [Related]
8. Factors predictive of relapse and spontaneous remission of autoimmune pancreatitis patients treated/not treated with corticosteroids.
Kubota K; Watanabe S; Uchiyama T; Kato S; Sekino Y; Suzuki K; Mawatari H; Iida H; Endo H; Fujita K; Yoneda M; Takahashi H; Kirikoshi H; Kobayashi N; Saito S; Sugimori K; Hisatomi K; Matsuhashi N; Sato H; Tanida E; Sakaguchi T; Fujisawa N; Nakajima A
J Gastroenterol; 2011 Jun; 46(6):834-42. PubMed ID: 21491208
[TBL] [Abstract][Full Text] [Related]
9. Lacrimal gland function in autoimmune pancreatitis.
Kamisawa T; Takuma K; Kuruma S; Fujiwara J; Anjiki H; Koizumi K; Egawa N; Kubota N; Ozaki N; Sasaki T
Intern Med; 2009; 48(12):939-43. PubMed ID: 19525578
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of positron emission tomography in the evaluation of distribution and activity of systemic lesions associated with autoimmune pancreatitis.
Matsubayashi H; Furukawa H; Maeda A; Matsunaga K; Kanemoto H; Uesaka K; Fukutomi A; Ono H
Pancreatology; 2009; 9(5):694-9. PubMed ID: 19684434
[TBL] [Abstract][Full Text] [Related]
11. Comparison of steroid pulse therapy and conventional oral steroid therapy as initial treatment for autoimmune pancreatitis.
Tomiyama T; Uchida K; Matsushita M; Ikeura T; Fukui T; Takaoka M; Nishio A; Okazaki K
J Gastroenterol; 2011 May; 46(5):696-704. PubMed ID: 21188426
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic strategy for autoimmune pancreatitis.
Kamisawa T; Satake K
Adv Med Sci; 2008; 53(2):145-8. PubMed ID: 18762470
[TBL] [Abstract][Full Text] [Related]
13. Appropriate steroid therapy for autoimmune pancreatitis based on long-term outcome.
Kamisawa T; Okamoto A; Wakabayashi T; Watanabe H; Sawabu N
Scand J Gastroenterol; 2008; 43(5):609-13. PubMed ID: 18415756
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic endocrine and exocrine function and salivary gland function in autoimmune pancreatitis before and after steroid therapy.
Kamisawa T; Egawa N; Inokuma S; Tsuruta K; Okamoto A; Kamata N; Nakamura T; Matsukawa M
Pancreas; 2003 Oct; 27(3):235-8. PubMed ID: 14508128
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic cystic lesions with atypical steroid response should be carefully managed in cases of autoimmune pancreatitis.
Matsubayashi H; Iwai T; Matsui T; Wada T; Kawata N; Ito H; Sasaki K; Uesaka K; Ono H
J Gastroenterol Hepatol; 2016 Jan; 31(1):270-6. PubMed ID: 26207936
[TBL] [Abstract][Full Text] [Related]
16. Qualitative and quantitative evaluation for morphological changes of the splenic artery in autoimmune pancreatitis: novel imaging findings for differentiation from pancreatic adenocarcinoma.
Toshima F; Inoue D; Komori T; Minehiro K; Yoneda N; Yoshida K; Matsubara T; Izumozaki A; Kobayashi S; Gabata T
Abdom Radiol (NY); 2018 Dec; 43(12):3357-3366. PubMed ID: 29948059
[TBL] [Abstract][Full Text] [Related]
17. The natural course of autoimmune pancreatitis.
Kamisawa T; Anjiki H; Takuma K; Egawa N; Kubota N
Hepatogastroenterology; 2009; 56(91-92):866-70. PubMed ID: 19621719
[TBL] [Abstract][Full Text] [Related]
18. Autoimmune pancreatitis: pancreatic and extrapancreatic MR imaging-MR cholangiopancreatography findings at diagnosis, after steroid therapy, and at recurrence.
Manfredi R; Frulloni L; Mantovani W; Bonatti M; Graziani R; Pozzi Mucelli R
Radiology; 2011 Aug; 260(2):428-36. PubMed ID: 21613442
[TBL] [Abstract][Full Text] [Related]
19. The relationship between pancreatic atrophy after steroid therapy and diabetes mellitus in patients with autoimmune pancreatitis.
Masuda A; Shiomi H; Matsuda T; Takenaka M; Arisaka Y; Azuma T; Kutsumi H
Pancreatology; 2014; 14(5):361-5. PubMed ID: 25278305
[TBL] [Abstract][Full Text] [Related]
20. Short-term and long-term outcomes of autoimmune pancreatitis.
Takuma K; Kamisawa T; Tabata T; Inaba Y; Egawa N; Igarashi Y
Eur J Gastroenterol Hepatol; 2011 Feb; 23(2):146-52. PubMed ID: 21287714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
